Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $110.00

Summary by themarketsdaily.com
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective hoisted by The Goldman Sachs Group from $108.00 to $110.00 in a report issued on Friday,MarketScreener reports. They currently have a neutral rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on GILD. Daiwa America upgraded Gilead Sciences […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

themarketsdaily.comthemarketsdaily.com

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $110.00

Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective hoisted by The Goldman Sachs Group from $108.00 to $110.00 in a report issued on Friday,MarketScreener reports. They currently have a neutral rating on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on GILD. Daiwa America upgraded Gilead Sciences […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Monday, November 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Gilead Sciences icon

Gilead Sciences

News
For You
SearchBlindspotLocal